TGFB2 and cancer: To examine the biological function of TGFβ2 in cancer motility, loss‐of‐function experiment and Boyden chamber assay was performed, and the results showed that knockdown of TGFβ2 significantly reduced the invasive potential of KYSE150 and KYSE30 cells (Figure 1L; Figure S1F, Supporting Information).